<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05099679</url>
  </required_header>
  <id_info>
    <org_study_id>60375</org_study_id>
    <secondary_id>PROS0109</secondary_id>
    <nct_id>NCT05099679</nct_id>
  </id_info>
  <brief_title>Pilot Study for Optimizing Mental Wellbeing &amp; Heart Health for Black Patients w/ Prostate Cancer</brief_title>
  <official_title>A Pilot Study for Optimizing Mental Wellbeing and Heart Health for Black Patients With Prostate Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation&#xD;
      services to address socioeconomic health disparities and improve wellbeing for black men with&#xD;
      prostate cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will see an oncology Associate Clinical Social Worker at Stanford's Cancer Center&#xD;
      for a two hour psychosocial assessment. Subsequently they will be offered up to 10 counseling&#xD;
      sessions with a clinical social worker, (Part A). If their physical status allows,&#xD;
      participants will also be given the opportunity to participate in a 12-week virtual&#xD;
      supervised cardiac rehabilitation program (Part B).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Completers</measure>
    <time_frame>12 weeks</time_frame>
    <description>Proportion of screened eligible participants who complete the initial 2-hour psychosocial support session intake.&#xD;
The pilot study is considered feasible if the primary endpoint is met in at least 50% of patients. We will evaluate the 95% CI of the feasibility rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in Patient Health Questionnaire-9 (PHQ-9)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference of General Anxiety Disorder-7 (GAD-7) score</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference of Functional Assessment of Cancer Therapy-Prostate (FACT-P) score</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Psychosocial intervention + Cardiac Rehab Services</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cognitive Behavioral Therapy + Cardiac Rehab</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive behavioral therapy (supportive counseling)</intervention_name>
    <description>Providing patients with a 2-hour psychosocial counseling intake (and if appropriate as assessed by clinical social worker, up to 10 subsequent counseling sessions).</description>
    <arm_group_label>Psychosocial intervention + Cardiac Rehab Services</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Virtual Cardiac Rehabilitation</intervention_name>
    <description>If eligible, patients will be referred to Moving Analytics Virtual Cardiac Rehabilitation to provide approximately 3 exercise sessions per week, with approximately eight coaching sessions over a 12 week period</description>
    <arm_group_label>Psychosocial intervention + Cardiac Rehab Services</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Inclusion Criteria Part A (Mental Health)&#xD;
&#xD;
          -  Self-Identify as Black and/or African American&#xD;
&#xD;
          -  Diagnosed with prostate cancer (per medical history; pathology not required) on Day 1,&#xD;
             or is currently, or was formerly, receiving androgen deprivation. It is acceptable for&#xD;
             participant to switch/transition to another form of androgen deprivation therapy while&#xD;
             in the study. Participant may be receiving or planning to receive additional systemic&#xD;
             therapy concurrent with androgen deprivation.&#xD;
&#xD;
          -  Males &gt;= age 18&#xD;
&#xD;
          -  Life expectancy of &gt;6 months&#xD;
&#xD;
          -  Ability to understand and the willingness to sign a written informed consent document&#xD;
             in English, and the willingness/ability to comply with the protocol activities.&#xD;
&#xD;
          -  Ability to wear a mask during all in-person sessions (when required).&#xD;
&#xD;
        Inclusion Criteria: Part B (Cardiac Services)&#xD;
&#xD;
          -  Have completed the 2-hour intake (as documented by clinical social worker) from Part&#xD;
             A. * ECOG Performance Status of &lt;= 2, or at the investigator's discretion, ability to&#xD;
             participate in a cardiac rehab program.&#xD;
&#xD;
          -  Participant must be able and willing to follow the cardiac rehabilitation activities.&#xD;
&#xD;
          -  Participant must be able to use a cardiac rehabilitation app on their smartphone or&#xD;
             tablet.&#xD;
&#xD;
        Exclusion Criteria: Part A (Mental Health Services)&#xD;
&#xD;
          -  Actively engaging in self harm, or currently on a 5150 or 5250.&#xD;
&#xD;
        Exclusion Criteria: Part B (Cardiac Services)&#xD;
&#xD;
          -  Uncontrolled angina, active acute coronary syndrome (e.g., unstable angina or acute&#xD;
             MI) or poorly controlled arrhythmias.&#xD;
&#xD;
          -  In the opinion of the Principal Investigator, have a clinically significant comorbid&#xD;
             disease that is likely to affect the ability of the patient to complete the trial,&#xD;
             interfere with their ability with measurement of self-reported outcomes.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Self-Identify as Black and/or African American</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alice Fan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Deirdre Crommie</last_name>
    <phone>(650) 387-7797</phone>
    <email>dcrommie@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Deirdre Crommie</last_name>
      <email>dcrommie@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Alice C Fan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 11, 2021</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

